Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma.
Blood
; 128(19): 2297-2306, 2016 11 10.
Article
in En
| MEDLINE
| ID: mdl-27647864
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thalidomide
/
Prednisone
/
Antineoplastic Combined Chemotherapy Protocols
/
Drug Resistance, Neoplasm
/
Cyclophosphamide
/
Multiple Myeloma
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood
Year:
2016
Type:
Article
Affiliation country:
Netherlands